AI in Drug Discovery Market Size, Share, Trends, Industry Analysis Report: By Offering, By Technology, By Therapeutic Area, By Application, By End User, and By Region

Description

List of Tables

The AI in drug discovery market size is expected to reach USD 26,497.79 million by 2034, according to a new study by Polaris Market Research. The report "AI in Drug Discovery Market Share, Size, Trends, Industry Analysis Report, By Offering (Software, Services), By Technology, By Therapeutic Area, By Application, By End User and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa); Segment Forecast, 2025 - 2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The AI in drug discovery market is experiencing rapid growth, due to rapid adoption of technological advancements, increasing healthcare needs, and evolving pharmaceutical industry dynamics. The escalating demand for more efficient and cost-effective drug development processes is driving demand for the AI in drug discovery market. Traditional drug discovery methods are often time-consuming and expensive, with high failure rates during clinical trials. AI offers a solution by accelerating the identification of potential drug candidates, predicting their efficacy and safety, and optimizing clinical trial designs. This reduces the time and cost associated with drug development, thus contributing to the market growth. Furthermore, the growing prevalence of chronic diseases and the increasing need for personalized medicine is driving demand for AI in drug discovery solutions. With rising aging population and increasing incidence of conditions such as cancer, diabetes, and cardiovascular diseases rises, there is a growing need for new and more effective therapies. AI technologies, including machine learning and deep learning, are particularly well-suited to analyzing large datasets and identifying patterns that may not be apparent through traditional methods. This capability enables the development of targeted therapies tailored to individual patient profiles, improving treatment outcomes and reducing adverse effects.

The adoption of AI in drug discovery is being fueled by substantial investments from both private and public sectors. Governments and healthcare organizations worldwide are recognizing the potential of AI to revolutionize the drug discovery process and are investing in research and development initiatives to foster innovation. Moreover, collaborations between AI technology companies and pharmaceutical giants are also on the rise, with partnerships aimed at integrating AI into various stages of drug development. These collaborations are further supported by advancements in computational power, cloud computing, and big data analytics, which provide the necessary infrastructure for AI applications in drug discovery.

AI in Drug Discovery Market Report Highlights

In 2024, the oncology segment accounted for the largest revenue share in the AI in drug discovery market due to the high demand for innovative cancer treatments and the complexity of cancer research, which benefits significantly from AI-driven solutions.

The pharmaceutical & biotechnology companies segment is anticipated to grow at the fastest CAGR due to their increasing adoption of AI technologies to accelerate drug discovery, reduce development costs, and enhance the precision and efficiency of drug development processes.

In 2024, North America accounted for the largest market share in the AI in drug discovery market due to its advanced healthcare infrastructure, high levels of investment in AI research, and the presence of major pharmaceutical and biotechnology companies leveraging AI for drug development.

The Asia Pacific region is expected to grow at the fastest CAGR in the forecast period due to a large and diverse patient population providing valuable data, and supportive government initiatives fostering innovation in drug discovery.

The global key market players include Atomwise Inc., BenevolentAI, Berg Health (Berg Health acquired by BPGbio Inc.), BioSymetrics, Inc., CYCLICA (Acquired by Recursion Pharmaceuticals), Exscientia, GNS Healthcare (the company Rebranded as Aitia), Google (DeepMind), IBM, Insilico Medicine, insitro.

Polaris Market Research has segmented the AI in drug discovery market report based on offering, technology, therapeutic area, application, end user, and region:

By Offering Outlook (Revenue - USD million, 2020-2034)

Software
Services

By Technology Outlook (Revenue - USD million, 2020-2034)

Machine Learning
Deep Learning
Supervised Learning
Reinforcement Learning
Unsupervised Learning
Other Machine Learning Technologies
Other Technologies

By Therapeutic Area Outlook (Revenue - USD million, 2020-2034)

Oncology
Neurodegenerative Diseases
Cardiovascular Disease
Metabolic Diseases
Infectious Disease
Others

By Application Outlook (Revenue - USD million, 2020-2034)

Drug optimization & repurposing
Preclinical testing
Others

By End User Outlook (Revenue - USD million, 2020-2034)

Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Research Centers
Academic & Government Institutes

By Regional Outlook (Revenue - USD million, 2020-2034)

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa

Product Code: PM1850

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global AI in Drug Discovery Market Insights

4.1. AI in Drug Discovery Market - Application Snapshot
4.2. AI in Drug Discovery Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Collaboration Between Pharma Companies and AI Providers is Driving Market Growth
  - 4.2.1.2. The Advancements in AI Technology Are Driving the Market Growth.
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Data Privacy and Security Concerns are limiting the growth of AI in Drug Discovery market
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. AI in Drug Discovery Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global AI in Drug Discovery Market, by Offering

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
5.3. Software
- 5.3.1. Global AI in Drug Discovery Market, by Software, by Region, 2020-2034 (USD Million)
5.4. Services
- 5.4.1. Global AI in Drug Discovery Market, by Services , by Region, 2020-2034 (USD Million)

6. Global AI in Drug Discovery Market, by Technology

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
6.3. Machine Learning
- 6.3.1. Global AI in Drug Discovery Market, by Machine Learning, by Region, 2020-2034 (USD Million)
- 6.3.2. Deep Learning
  - 6.3.2.1. Global AI in Drug Discovery Market, by Deep Learning, by Region, 2020-2034 (USD Million)
- 6.3.3. Supervised Learning
  - 6.3.3.1. Global AI in Drug Discovery Market, by Supervised Learning, by Region, 2020-2034 (USD Million)
- 6.3.4. Reinforcement Learning
  - 6.3.4.1. Global AI in Drug Discovery Market, by Reinforcement Learning, by Region, 2020-2034 (USD Million)
- 6.3.5. Unsupervised Learning
  - 6.3.5.1. Global AI in Drug Discovery Market, by Unsupervised Learning, by Region, 2020-2034 (USD Million)
- 6.3.6. Other Machine Learning Technologies
  - 6.3.6.1. Global AI in Drug Discovery Market, by Other Machine Learning Technologies, by Region, 2020-2034 (USD Million)
6.4. Other Technologies
- 6.4.1. Global AI in Drug Discovery Market, by Other Technologies, by Region, 2020-2034 (USD Million)

7. Global AI in Drug Discovery Market, by Therapeutic Area

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
7.3. Oncology
- 7.3.1. Global AI in Drug Discovery Market, by Oncology, by Region, 2020-2034 (USD Million)
7.4. Neurodegenerative Diseases
- 7.4.1. Global AI in Drug Discovery Market, by Neurodegenerative Diseases, by Region, 2020-2034 (USD Million)
7.5. Cardiovascular Disease
- 7.5.1. Global AI in Drug Discovery Market, by Cardiovascular Disease, by Region, 2020-2034 (USD Million)
7.6. Metabolic Diseases
- 7.6.1. Global AI in Drug Discovery Market, by Metabolic Diseases, by Region, 2020-2034 (USD Million)
7.7. Infectious Disease
- 7.7.1. Global AI in Drug Discovery Market, by Infectious Disease, by Region, 2020-2034 (USD Million)
7.8. Others
- 7.8.1. Global AI in Drug Discovery Market, by Others, by Region, 2020-2034 (USD Million)

8. Global AI in Drug Discovery Market, by Application

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
8.3. Drug optimization & repurposing
- 8.3.1. Global AI in Drug Discovery Market, by Drug optimization & repurposing, by Region, 2020-2034 (USD Million)
8.4. Preclinical testing
- 8.4.1. Global AI in Drug Discovery Market, by Preclinical testing, by Region, 2020-2034 (USD Million)
8.5. Others
- 8.5.1. Global AI in Drug Discovery Market, by Others, by Region, 2020-2034 (USD Million)

9. Global AI in Drug Discovery Market, by End User

9.1. Key Findings
9.2. Introduction
- 9.2.1. Global AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
9.3. Pharmaceutical & Biotechnology Companies
- 9.3.1. Global AI in Drug Discovery Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020-2034 (USD Million)
9.4. Contract Research Organizations
- 9.4.1. Global AI in Drug Discovery Market, by Contract Research Organizations, by Region, 2020-2034 (USD Million)
9.5. Research Centers
- 9.5.1. Global AI in Drug Discovery Market, by Research Centers, by Region, 2020-2034 (USD Million)
9.6. Academic & Government Institutes
- 9.6.1. Global AI in Drug Discovery Market, by Academic & Government Institutes, by Region, 2020-2034 (USD Million)

10. Global AI in Drug Discovery Market, by Geography

10.1. Key Findings
10.2. Introduction
- 10.2.1. AI in Drug Discovery Market Assessment, By Geography, 2020-2034 (USD Million)
10.3. AI in Drug Discovery Market - North America
- 10.3.1. North America: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
- 10.3.2. North America: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
- 10.3.3. North America: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
- 10.3.4. North America: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
- 10.3.5. North America: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.3.7. AI in Drug Discovery Market - U.S.
  - 10.3.7.1. U.S.: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.3.7.2. U.S.: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.3.7.3. U.S.: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.3.7.4. U.S.: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.3.7.5. U.S.: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.3.8. AI in Drug Discovery Market - Canada
  - 10.3.8.1. Canada: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.3.8.2. Canada: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.3.8.3. Canada: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.3.8.4. Canada: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.3.8.5. Canada: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.4. AI in Drug Discovery Market - Europe
- 10.4.1. Europe: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
- 10.4.2. Europe: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
- 10.4.3. Europe: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
- 10.4.4. Europe: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
- 10.4.5. Europe: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.4.6. AI in Drug Discovery Market - UK
  - 10.4.6.1. UK: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.4.6.2. UK: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.4.6.3. UK: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.4.6.4. UK: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.4.6.5. UK: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.4.7. AI in Drug Discovery Market - France
  - 10.4.7.1. France: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.4.7.2. France: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.4.7.3. France: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.4.7.4. France: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.4.7.5. France: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.4.8. AI in Drug Discovery Market - Germany
  - 10.4.8.1. Germany: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.4.8.2. Germany: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.4.8.3. Germany: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.4.8.4. Germany: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.4.8.5. Germany: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.4.9. AI in Drug Discovery Market - Italy
  - 10.4.9.1. Italy: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.4.9.2. Italy: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.4.9.3. Italy: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.4.9.4. Italy: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.4.9.5. Italy: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.4.10. AI in Drug Discovery Market - Spain
  - 10.4.10.1. Spain: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.4.10.2. Spain: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.4.10.3. Spain: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.4.10.4. Spain: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.4.10.5. Spain: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.4.11. AI in Drug Discovery Market - Netherlands
  - 10.4.11.1. Netherlands: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.4.11.2. Netherlands: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.4.11.3. Netherlands: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.4.11.4. Netherlands: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.4.11.5. Netherlands: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.4.12. AI in Drug Discovery Market - Russia
  - 10.4.12.1. Russia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.4.12.2. Russia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.4.12.3. Russia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.4.12.4. Russia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.4.12.5. Russia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.4.13. AI in Drug Discovery Market - Rest of Europe
  - 10.4.13.1. Rest of Europe: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.4.13.2. Rest of Europe: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.4.13.3. Rest of Europe: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.4.13.4. Rest of Europe: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.4.13.5. Rest of Europe: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.5. AI in Drug Discovery Market - Asia Pacific
- 10.5.1. Asia Pacific: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
- 10.5.2. Asia Pacific: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
- 10.5.3. Asia Pacific: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
- 10.5.4. Asia Pacific: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
- 10.5.5. Asia Pacific: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.5.6. AI in Drug Discovery Market - China
  - 10.5.6.1. China: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.5.6.2. China: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.5.6.3. China: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.5.6.4. China: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.5.6.5. China: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.5.7. AI in Drug Discovery Market - India
  - 10.5.7.1. India: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.5.7.2. India: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.5.7.3. India: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.5.7.4. India: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.5.7.5. India: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.5.8. AI in Drug Discovery Market - Malaysia
  - 10.5.8.1. Malaysia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.5.8.2. Malaysia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.5.8.3. Malaysia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.5.8.4. Malaysia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.5.8.5. Malaysia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.5.9. AI in Drug Discovery Market - Japan
  - 10.5.9.1. Japan: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.5.9.2. Japan: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.5.9.3. Japan: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.5.9.4. Japan: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.5.9.5. Japan: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.5.10. AI in Drug Discovery Market - Indonesia
  - 10.5.10.1. Indonesia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.5.10.2. Indonesia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.5.10.3. Indonesia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.5.10.4. Indonesia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.5.10.5. Indonesia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.5.11. AI in Drug Discovery Market - South Korea
  - 10.5.11.1. South Korea: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.5.11.2. South Korea: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.5.11.3. South Korea: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.5.11.4. South Korea: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.5.11.5. South Korea: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.5.12. AI in Drug Discovery Market - Australia
  - 10.5.12.1. Australia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.5.12.2. Australia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.5.12.3. Australia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.5.12.4. Australia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.5.12.5. Australia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.5.13. AI in Drug Discovery Market - Rest of Asia Pacific
  - 10.5.13.1. Rest of Asia Pacific: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.5.13.2. Rest of Asia Pacific: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.5.13.3. Rest of Asia Pacific: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.5.13.4. Rest of Asia Pacific: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.5.13.5. Rest of Asia Pacific: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.6. AI in Drug Discovery Market - Middle East & Africa
- 10.6.1. Middle East & Africa: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
- 10.6.2. Middle East & Africa: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
- 10.6.3. Middle East & Africa: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
- 10.6.4. Middle East & Africa: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
- 10.6.5. Middle East & Africa: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.6.6. AI in Drug Discovery Market - Saudi Arabia
  - 10.6.6.1. Saudi Arabia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.6.6.2. Saudi Arabia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.6.6.3. Saudi Arabia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.6.6.4. Saudi Arabia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.6.6.5. Saudi Arabia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.6.7. AI in Drug Discovery Market - UAE
  - 10.6.7.1. UAE: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.6.7.2. UAE: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.6.7.3. UAE: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.6.7.4. UAE: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.6.7.5. UAE: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.6.8. AI in Drug Discovery Market - Israel
  - 10.6.8.1. Israel: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.6.8.2. Israel: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.6.8.3. Israel: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.6.8.4. Israel: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.6.8.5. Israel: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.6.9. AI in Drug Discovery Market - South Africa
  - 10.6.9.1. South Africa: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.6.9.2. South Africa: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.6.9.3. South Africa: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.6.9.4. South Africa: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.6.9.5. South Africa: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.6.10. AI in Drug Discovery Market - Rest of Middle East & Africa
  - 10.6.10.1. Rest of Middle East & Africa: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.6.10.2. Rest of Middle East & Africa: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.6.10.3. Rest of Middle East & Africa: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.6.10.4. Rest of Middle East & Africa: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.6.10.5. Rest of Middle East & Africa: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.7. AI in Drug Discovery Market - Latin America
- 10.7.1. Latin America: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
- 10.7.2. Latin America: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
- 10.7.3. Latin America: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
- 10.7.4. Latin America: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
- 10.7.5. Latin America: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.7.6. AI in Drug Discovery Market - Mexico
  - 10.7.6.1. Mexico: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.7.6.2. Mexico: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.7.6.3. Mexico: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.7.6.4. Mexico: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.7.6.5. Mexico: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.7.7. AI in Drug Discovery Market - Brazil
  - 10.7.7.1. Brazil: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.7.7.2. Brazil: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.7.7.3. Brazil: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.7.7.4. Brazil: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.7.7.5. Brazil: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.7.8. AI in Drug Discovery Market - Argentina
  - 10.7.8.1. Argentina: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.7.8.2. Argentina: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.7.8.3. Argentina: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.7.8.4. Argentina: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.7.8.5. Argentina: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
- 10.7.9. AI in Drug Discovery Market - Rest of Latin America
  - 10.7.9.1. Rest of Latin America: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  - 10.7.9.2. Rest of Latin America: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  - 10.7.9.3. Rest of Latin America: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 10.7.9.4. Rest of Latin America: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  - 10.7.9.5. Rest of Latin America: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)

11. Competitive Landscape

11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

12.1. Atomwise Inc.
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
12.2. BenevolentAI
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
12.3. Berg Health
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
12.4. BioSymetrics, Inc.
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
12.5. CYCLICA
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
12.6. Exscientia
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
12.7. GNS Healthcare
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
12.8. Google
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
12.9. IBM
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
12.10. Insilico Medicine
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
12.11. insitro
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development